-
My Account
My Account
BSE Live
Apr 16, 16:00Prev. Close
1703.05
Open Price
1705.00
Bid Price (Qty.)
1720.00 (11)
Offer Price (Qty.)
1726.00 (122)
NSE Live
Apr 16, 15:57Prev. Close
1709.60
Open Price
1710.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Half Yearly Results of Ajanta Pharma (in Rs. Cr.) | Sep '20 | Mar '20 | Sep '19 | Mar '19 | Sep '18 | |
| Net Sales/Income from operations | 1,237.36 | 1,091.23 | 1,105.19 | 865.38 | 907.24 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 1,237.36 | 1,091.23 | 1,105.19 | 865.38 | 907.24 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 340.92 | 309.29 | 246.93 | 207.36 | 181.35 | |
| Purchase of Traded Goods | 51.12 | 47.81 | 50.92 | 39.73 | 31.06 | |
| Increase/Decrease in Stocks | -66.91 | -28.14 | 37.16 | -30.56 | -36.82 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 241.98 | 224.28 | 213.54 | 197.21 | 192.16 | |
| Depreciation | 54.06 | 47.39 | 43.90 | 36.48 | 33.42 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 245.98 | 293.86 | 267.99 | 253.38 | 256.54 | |
| P/L Before Other | 370.21 | 196.74 | 244.75 | 161.78 | 249.53 | |
| Other Income | 99.34 | 105.27 | 78.93 | 16.16 | 85.99 | |
| P/L Before Int. | 469.55 | 302.01 | 323.68 | 177.94 | 335.52 | |
| Interest | 2.55 | 3.77 | 5.33 | 0.23 | 0.18 | |
| P/L Before Exceptional Items & Tax | 467.00 | 298.24 | 318.35 | 177.71 | 335.34 | |
| Exceptional Items | -- | -2.85 | -1.07 | -- | -- | |
| P/L Before Tax | 467.00 | 295.39 | 317.28 | 177.71 | 335.34 | |
| Tax | 126.09 | 98.56 | 72.98 | 40.87 | 80.42 | |
| P/L After Tax from Ordinary Activities | 340.91 | 196.83 | 244.30 | 136.84 | 254.92 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 340.91 | 196.83 | 244.30 | 136.84 | 254.92 | |
| Equity Share Capital | 17.54 | 17.54 | 17.54 | 17.54 | 17.69 | |
| Reserves Excluding Revaluation Reserves | 2,783.74 | -- | 2,363.75 | -- | 2,168.36 | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 39.07 | 22.44 | 28.00 | -- | 28.96 | |
| Diluted EPS | 39.07 | -- | 28.00 | -- | 28.96 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 39.07 | 22.44 | 28.00 | -- | 28.96 | |
| Diluted EPS. | 39.07 | -- | 28.00 | -- | 28.96 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
12.02.2021
09.02.2021
03.02.2021
Ajanta Pharma share price jumps 7%, hits 52-week high as Q3 PAT zooms 64%
03.02.2021
Ajanta Pharma Standalone December 2020 Net Sales at Rs 733.16 crore, up 38.19% Y-o-Y
03.02.2021
Ajanta Pharma Standalone December 2020 Net Sales at Rs 733.16 crore, up 38.19% Y-o-Y
02.02.2021
02.02.2021
Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
04.11.2020
Ajanta Pharma Consolidated September 2020 Net Sales at Rs 715.91 crore, up 11.38% Y-o-Y
